Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000712831 | SCV000233121 | uncertain significance | not provided | 2017-12-22 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000712831 | SCV000617873 | uncertain significance | not provided | 2023-08-28 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 32906206, 30564623) |
Labcorp Genetics |
RCV001088687 | SCV000770000 | likely benign | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2; Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2; Autosomal recessive limb-girdle muscular dystrophy type 2N | 2024-01-17 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000712831 | SCV000843366 | uncertain significance | not provided | 2018-01-25 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000712831 | SCV003809721 | uncertain significance | not provided | 2023-01-13 | criteria provided, single submitter | clinical testing |